Immix Biopharma, Inc. Increase (Decrease) in Interest Payable, Net
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInterestPayableNet · last filed 2024-03-29
- Immix Biopharma, Inc. increase (decrease) in interest payable, net for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- Immix Biopharma, Inc. increase (decrease) in interest payable, net for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- Immix Biopharma, Inc. increase (decrease) in interest payable, net for the quarter ending 2022-06-30 was -$9.41K, a 127.61% decline year-over-year.
- Immix Biopharma, Inc. increase (decrease) in interest payable, net for the quarter ending 2022-03-31 was $308.00, a 98.81% decline year-over-year.
- Immix Biopharma, Inc. increase (decrease) in interest payable, net for fiscal 2022 was -$9.10K, a 107.57% decline from fiscal 2021.
- Immix Biopharma, Inc. increase (decrease) in interest payable, net for fiscal 2021 was $120.15K, a 18.87% increase from fiscal 2020.
- Immix Biopharma, Inc. increase (decrease) in interest payable, net for fiscal 2020 was $101.08K.
| Period end | Increase (Decrease) in Interest Payable, Net 3 month | Increase (Decrease) in Interest Payable, Net 6 month | Increase (Decrease) in Interest Payable, Net 9 month | Increase (Decrease) in Interest Payable, Net 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $0.00 derived: sum of 2 quarters · filed 2024-03-29 | -$9.41K derived: sum of 3 quarters · filed 2024-03-29 | -$9.10K 10-K · filed 2024-03-29 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$9.41K derived: sum of 2 quarters · filed 2023-11-13 | -$9.10K 10-Q · filed 2023-11-13 | $17.90K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$9.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$9.10K 10-Q · filed 2023-08-11 | $17.90K derived: sum of 3 quarters · filed 2023-08-11 | $51.13K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $308.00 10-Q · filed 2023-05-12 | $27.31K derived: sum of 2 quarters · filed 2023-05-12 | $60.53K derived: sum of 3 quarters · filed 2023-05-12 | $94.61K derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $60.23K derived: sum of 2 quarters · filed 2023-03-27 | $94.30K derived: sum of 3 quarters · filed 2023-03-27 | $120.15K 10-K · filed 2023-03-27 |
| 2021-09-30 | $33.22K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $67.30K derived: sum of 2 quarters · filed 2022-11-09 | $93.15K 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $34.08K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $59.93K 10-Q · filed 2022-08-12 | ||
| 2021-03-31 | $25.85K 10-Q · filed 2022-05-13 | |||
| 2020-12-31 | $101.08K 10-K · filed 2022-03-28 |